The Impact of AI-Based Fundus Imaging on Blood Glucose Control and Fundus Examination Completion Rates in Outpatient Diabetic Patients
1 other identifier
interventional
200
1 country
1
Brief Summary
This study aims to evaluate the impact of AI-based fundus imaging on blood glucose control and fundus examination completion rates in diabetic patients by comparing outcomes between those who undergo AI fundus imaging and those who do not. The study is designed as a parallel randomized controlled trial (RCT). Using a random number table, 200 diabetic patients visiting the Department of Endocrinology at Sichuan Provincial People's Hospital between December 2024 and December 2025 will be equally divided into two groups: an intervention group and a control group. Each group will consist of 100 patients, assigned unique random numbers. The intervention group will undergo AI-based fundus imaging once, with the imaging process taking approximately 5 minutes. The control group will receive standard eye health education without AI fundus imaging. The primary outcomes, including blood glucose control, systemic indicators, and fundus examination completion rates, will be assessed and compared between the two groups at 3-month and 6-month follow-ups. This study seeks to determine the value of AI-based fundus imaging in improving diabetes management and complication prevention in diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes
Started Dec 2024
Shorter than P25 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 26, 2024
CompletedFirst Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 26, 2025
CompletedFebruary 11, 2025
February 1, 2025
1 year
February 5, 2025
February 10, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
fasting blood glucose level
Blood Glucose Control Status in Two Groups of Patients
From enrollment to reexamination at 3 months and 6 months
Blood Glucose Control Status in Two Groups of Patients after 3 Months and 6 Months
glycated hemoglobin (HbA1c) level
From enrollment to reexamination at 3 months and 6 months
Study Arms (2)
Patients with diabetes who received health education and AI fundus photography in our hospital
EXPERIMENTALPatients with diabetes who received health education in our hospital
NO INTERVENTIONInterventions
In the dark room, Canon CR-2AF automatic mydria-free fundus camera was used to collect images of both eyes of the patients, and one fundus photo was taken with macula as the center of each eye
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years.
- Diagnosis of Type 2 Diabetes Mellitus.
- Patients with a glycated hemoglobin (HbA1c) level \> 7%.
- Ability to comply with all required examinations and provide signed informed consent.
You may not qualify if:
- No previous diabetic fundus examination.
- No known diabetic retinopathy.
- Absence of other ocular diseases that could lead to retinopathy.
- Subjects from whom clear fundus photographs could not be obtained.
- Patients with comorbid malignant tumors or severe cardiovascular diseases.
- Patients anticipated to have difficulties with follow-up or those residing in other provinces.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jie Lilead
Study Sites (1)
Sichuan Academy of Medical Sciences - Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610014, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 11, 2025
Study Start
December 26, 2024
Primary Completion
December 26, 2025
Study Completion
December 26, 2025
Last Updated
February 11, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 2025 and forever
- Access Criteria
- via https://pan.baidu.com
2030, via https://pan.baidu.com